Track record · closed signal

Innoviva Inc (INVA) — closed signal from May 15, 2026

Partial Published before the outcome was known, scored automatically when the window closed on August 13, 2026.

Predicted vs. what happened

INVA price · publication thesis → realized outcomesplit-adjusted
$22.62 Published $26.24 Target $20.75 Window close $24.17 Peak
$21.80 – $22.80Entry zone — fair-value band
$22.62Published — price the day we called it
$26.24Target — the price the thesis aimed for
$24.17Peak — highest point inside the window, not a realized return
$20.75Window close — end-of-window price, context only

What happened

Partial

Reached 43% of the predicted growth at its peak, without hitting the target.

Peak price
$24.17
peak on June 24, 2026 — not a realized return
Peak gain
+6.8%
peak, from the publication price
Window close
$20.75
end-of-window price, context only
Days to target
Window
May 15, 2026 – August 13, 2026

The thesis — published May 15, 2026

Predicted growth
+16%
over the measurement window
Target price
$26.24
the price the thesis aimed for
Entry zone
$21.80 – $22.80
the fair-value band we waited for
Price at publication
$22.62
published May 15, 2026
Confidence
72%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Innoviva offers steadier healthcare exposure because it earns recurring payments from drug royalties. A recent positive note from Cantor highlights those steady payments, which supports the idea the stock has underlying value. Trading has been thin and the business setup is complex, so conviction is limited; a short-term rebound looks possible if trading volume improves.

Primary drivers

  • Regular royalty payments create predictable cash flow for the healthcare business
  • Cantor's positive view underscores the strength of recurring royalty income
  • Lower price swings mean the stock can add steadier healthcare exposure
  • Very light trading and high short interest make conviction cautious

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.